In the Langley study, when studying proteins-potential biomarkers of atherosclerosis progression, four proteins (matrix metalloproteinase 9, calprotectin, cathepsin D and galectin-3) were identified, which made it possible to improve the prediction of the risk of complications of the atherosclerotic process [28]. The gene discussed is MMP9; the disease is atherosclerosis.